ARCH Venture Partners

Venture Capital

Profile

Investments
132
Companies
61

Capital

Total Deployed
$18.9B
Lead Rounds
27

Portfolio

61 companies
Prometheus $18.2B
Private San Francisco, USA
Xaira Therapeutics $1.6B
Private South San Francisco, United States
Ember Bio AI $369M
Private Cambridge, United States
Coral Bio AI $364M
Private Cambridge, United States
Ursa Bio $352M
Private Boston, United States
Meadow Bio $292M
Private Cambridge, United States
Pearl Bio $159M
Private San Francisco, United States
Dahlia Bio $154M
Private Cambridge, United States
Bay Bio $154M
Private San Francisco, United States
Cypress Bio $154M
Private Boston, United States
Anchor Bio $149M
Private Cambridge, United States
Wren Biotech $148M
Private Cambridge, United States
Verdant Bio $147M
Private Cambridge, United States
Larch Bio $146M
Private Cambridge, United States
Magnolia Bio $143M
Private Cambridge, United States
Bloom Bio $142M
Private Cambridge, United States
Cove Bio $139M
Private Cambridge, United States
Dawn Bio $138M
Private Cambridge, United States
Sable Bio $134M
Private San Francisco, United States
CREATE Medicines $122M
Private Cambridge, United States
Sunrise Robotics $109M
Private Boston, United States
Basalt Bio $57M
Private Cambridge, United States
Inlet Bio $57M
Private Boston, United States
Silver Bio $57M
Private Cambridge, United States
Robin Bio $57M
Private Cambridge, United States
Sable Bio Sciences $57M
Private Cambridge, United States
Ember Bio Sciences $57M
Private Cambridge, United States
Kelvin Bio $57M
Private Boston, United States
Tara Bio $56M
Private Boston, United States
Beam Bio $56M
Private Cambridge, United States
Vine Bio $56M
Private Cambridge, United States
Dune Bio $56M
Private Cambridge, United States
Aspen Bio $56M
Private San Francisco, United States
Summit Bio $56M
Private Cambridge, United States
Cinder Bio Sciences $56M
Private Cambridge, United States
Rhythm Biotech $56M
Private Boston, United States
Fern Bio $56M
Private Boston, United States
Prism Biotech $55M
Private San Francisco, United States
Olive Bio $54M
Private Cambridge, United States
Petal Bio Sciences $54M
Private Boston, United States
Boulevard Biotech $53M
Private Cambridge, United States
Beacon Bio $53M
Private Cambridge, United States
Grove Bio Sciences $53M
Private Boston, United States
Basil Bio $52M
Private Cambridge, United States
Sunday Bio $52M
Private Boston, United States
Petal Bio $51M
Private San Francisco, United States
Willow Bio $51M
Private San Francisco, United States
Aster Bio $50M
Private San Francisco, United States
Coral Bio Sciences $50M
Private San Francisco, United States
Grove Bio $49M
Private San Francisco, United States
Boulevard Bio $49M
Private Cambridge, United States
Almond Bio $48M
Private Cambridge, United States
Petal Robotics AI $36M
Private Boston, United States
Cinder Bio $15M
Private Boston, United States
Kepler Bio $15M
Private Cambridge, United States
Larkspur Biotech $14M
Private Cambridge, United States
Sunrise Bio $13M
Private Cambridge, United States
Wren Genetics $13M
Private Seattle, United States
Ember Bio $12M
Private Boston, United States
Cascade Genomics $12M
Private San Francisco, United States
Fossil Ventures Biotech $10M
Private San Diego, United States

Investment data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.